A clinical formulation indicated for Addiction & Quit Smoking. Promotes chemical receptor binding to assist in reducing nicotine withdrawal sensations.
A specialized aid indicated to manage nicotine withdrawal and intended to alleviate the rewarding effects of smoking to support successful cessation efforts.
Mechanism of Action
It binds partially to nicotinic receptors. This mimics nicotine to reduce withdrawal and blocks real nicotine from binding, making smoking less pleasurable.
Route of Administration
Oral
Onset Time
1 week before quit date
Duration
12 weeks
Contraindications
Severe renal impairment (dose adjustment), Allergy to varenicline
Information for Varenicline is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.
